EUVIMEDOpdag EUVIMED
Multizentrische StudieVergleichsstudie

Is mesh related morbidity the real thread in ventral rectopexy? Results of a retrospective international multicentre comparative analysis of biologic versus synthetic mesh

Sebastian Christen iD, Emma Barron, Daniel Gidl, Emily Khoo, Mark Potter iD, Nadja Stuebi, Verena Geissbuehler iD, Stefan Riss iD, Marco von Strauss iD, Mhairi Collie iD, Daniel C Steinemann iD

Colorectal Disease · 2025

DOI: 10.1111/codi.17273 ↗

At a glance

Multizentrische Studie in Colorectal Disease, 2025. Written by Sebastian Christen and 10 co-authors. Institution: Department of Visceral Surgery, University Digestive Health Care Centre Basel-Clarunis, Basel, Switzerland. Major MEDLINE topics: Postoperative Complications, Rectal Prolapse, Recurrence, Reoperation. Cited 2 times so far (Crossref); 24 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aim

Ventral mesh rectopexy (VMR) is an established surgical treatment for rectal prolapse and outlet obstruction. In contrast to continental Europe, in the UK and US the use of synthetic mesh has been abandoned in favour of biologic mesh, due to concerns regarding mesh related morbidity. The current study investigated if either material is superior, in terms of clinical recurrence and mesh related complications.

Methods

VMRs performed between March 2012 and July 2022 in three international pelvic floor centres were prospectively collected and retrospectively analysed, to look at the rate of complications and need for further therapy, including reoperation.

Results

A total of 360 patients were included in the study (140 biologic mesh (bm) / 220 synthetic mesh (sm)). Postoperative complication occurred in 5.7% in bmVMR (5% minor [Clavien‐Dindo I and II] and 0.7% major [Clavien‐Dindo > = III]) and in 10.9% in smVMR (9.1% minor and 1.8% major) ( p = 0.28). Oral laxatives were necessary in 31% after bmVMR and in 35% after smVMR ( p = 0.49). Rectal laxatives were used in 11% after bmVMR and in 7% after smVMR ( p = 0.34). Clinical recurrence appeared in 9% bmVMR and in 5% smVMR ( p = 0.20). Mean time to clinical recurrence in bmVMR was 20.9 (5 to 58) months and in smVMR 20.2 (0–55) months ( p = 0.75). Mean overall follow‐up time was 18.4 (0–96) months. Reoperation rate due to clinical recurrence was 6.11% in the bmVMR group versus 2.75% in the smVMR group ( p = 0.16). No mesh associated complications such as symptomatic erosion or fistulation occurred in either group.

Conclusion

VMR using biologic mesh was equally safe to that using synthetic mesh, with no difference in clinical recurrence rate. No mesh‐associated morbidity was observed in either group.

Subjects

MeSH terms (MEDLINE)

Postoperative ComplicationsRectal ProlapseRecurrenceReoperationSurgical MeshAgedFemaleHumansMaleMiddle AgedRectumRetrospective StudiesTreatment OutcomeFollow-Up Studies

Author keywords

biologic meshpelvic floor repairsynthetic meshventral mesh rectopexy

Authors and institutions

  • Department of Visceral Surgery, University Digestive Health Care Centre Basel-Clarunis, Basel, Switzerland.
  • The Edinburgh Colorectal Unit, Western General Hospital, Edinburgh, United Kingdom of Great Britain and Northern Ireland.
  • Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Faculty of medicine, University of Basel, Basel, Switzerland.
  • Urogynecology, St Clara Hospital, University of Basel, Basel, Switzerland.
  • Department of Gynecology, University of Basel, Basel, Switzerland.

ORCID profiles: Sebastian Christen, Mark Potter, Verena Geissbuehler, Stefan Riss, Marco von Strauss, Mhairi Collie, Daniel C Steinemann

Cite

APA

Christen, S., Barron, E., Gidl, D., Khoo, E., Potter, M., Stuebi, N., Geissbuehler, V., Riss, S., von Strauss, M., Collie, M., & Steinemann, D. C. (2025). Is mesh related morbidity the real thread in ventral rectopexy? Results of a retrospective international multicentre comparative analysis of biologic versus synthetic mesh. Colorectal Disease. https://doi.org/10.1111/codi.17273

Vancouver

Christen S, Barron E, Gidl D, Khoo E, Potter M, Stuebi N, et al. Is mesh related morbidity the real thread in ventral rectopexy? Results of a retrospective international multicentre comparative analysis of biologic versus synthetic mesh. Colorectal Disease. 2025. doi:10.1111/codi.17273

BibTeX
@article{Christen2025,
  author = {Christen, Sebastian and Barron, Emma and Gidl, Daniel and Khoo, Emily and Potter, Mark and Stuebi, Nadja and Geissbuehler, Verena and Riss, Stefan and von Strauss, Marco and Collie, Mhairi and Steinemann, Daniel C},
  title = {Is mesh related morbidity the real thread in ventral rectopexy? Results of a retrospective international multicentre comparative analysis of biologic versus synthetic mesh},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.17273}
}
Start for free →